一次自救，“奥特曼”竟埋下百亿元损失的“时间炸弹”

Core Insights - The article highlights the dissatisfaction of parents regarding the quality and pricing of the "Ultraman" children's theater performances, which are significantly more expensive than movie tickets, leading to complaints about misleading advertising and poor execution [1][2][3] Group 1: Performance Quality and Consumer Experience - Parents reported that the performances, priced at six times that of movie tickets, failed to deliver promised experiences, such as VIP packages and quality production values, resulting in disappointment for both children and parents [2][3] - The performances were criticized for lacking professional production elements, with costumes that did not adequately conceal performers and overall poor audio-visual quality [2][3] - Legal experts indicated that consumers could claim refunds based on misleading advertising and unmet contractual obligations, emphasizing the need for higher quality standards in children's cultural products [3] Group 2: Licensing and Authorization Issues - The article discusses the confusion surrounding the licensing of "Ultraman" performances, noting that multiple companies hold different rights to the IP, leading to inconsistencies in quality and pricing [6][7] - The authorization fees for performances can be as low as 3,000 yuan per show, raising concerns about the quality of productions that can be offered at such low costs [5][6] - The original rights holder, New Chuanghua, has not authorized cinema performances, indicating potential unauthorized use of the IP by other companies [5][6] Group 3: Market Dynamics and Financial Implications - The article outlines the significant financial potential of the "Ultraman" IP, with estimates suggesting that the licensing and derivative product market could be worth tens of billions, highlighting the long-term financial impact of historical licensing decisions [7][9] - Companies leveraging the "Ultraman" IP have seen substantial revenue growth, with examples of firms achieving over 100 billion yuan in revenue due to successful product lines based on the IP [9][10] - The fragmented licensing landscape has led to market confusion and varying product quality, which could harm the brand's reputation and consumer trust [8][10]